NOBILIS IB MA5
NOBILIS IB MA5
Authorised
- Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
Product identification
Medicine name:
NOBILIS IB MA5
Active substance:
- Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
Target species:
-
Chicken (hen)
-
Chicken (chick, for replacement)
-
Chicken (broiler)
Route of administration:
-
Nebulisation use
-
In drinking water use
-
Oculonasal use
Product details
Active substance and strength:
-
Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live3.0050% Embryo Infective Dose1.00Dose
Pharmaceutical form:
-
Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
-
Nebulisation use
- Chicken (hen)
-
Meat and offal0day
-
- Chicken (chick, for replacement)
-
Meat and offal0day
-
- Chicken (broiler)
-
Meat and offal0day
-
-
In drinking water use
- Chicken (hen)
-
Meat and offal0day
-
- Chicken (chick, for replacement)
-
Meat and offal0day
-
- Chicken (broiler)
-
Meat and offal0day
-
-
Oculonasal use
- Chicken (hen)
-
Meat and offal0day
-
- Chicken (chick, for replacement)
-
Meat and offal0day
-
- Chicken (broiler)
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Package description:
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
- Available only in Spanish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- Spanish Agency For Medicines And Health Products
Authorisation number:
- 2361 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 7/03/2024
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 7/03/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 7/03/2024
How useful was this page?: